Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells

Blood

Volumn 88, Issue 12, 1996, Pages 4526-4533

  Sindre, Hilde ^a   Tjønnfjord, Geir E ^a   Rollag, Halvor ^a   Ranneberg Nilsen, Toril ^a   Veiby, Ole Petter ^a   Beck, Solveig ^a   Degré, Miklos ^a   Hestdal, Kjetil ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURST FORMING UNIT E; CELL PROLIFERATION; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CYTOMEGALOVIRUS INFECTION; HEMATOPOIETIC STEM CELL; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0029912732     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4526.bloodjournal88124526     Document Type: Article

References (54)

1. Fiala M, Payne JE, Perne TV, Moore TC, Henle W, Montgomerie JZ, Chatterjee SN, Guze LB: Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis 132:421, 1975
2. Drew W: Cytomegalovirus infection in patients with AIDS. J Infect Dis 158:449, 1988
3. Rubin RH: Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 12:754, 1990 (suppl)
4. Adler S: Transfusion-associated cytomegalovirus infections. Rev Infect Dis 5:977, 1983
5. Betts RF, Freeman RB, Douglas RJ, Talley TE: Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child 131:759, 1977
6. Chou S: Acquisition of donor strains of cytomegalovirus by renal transplant recipients. N Engl J Med 314:1418, 1986
7. Fox AS, Tolpin MD, Baker AL, Broelsch CE, Whittington PF, Jackson T, Thistletwaite JR, Stuart FP: Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis 157:383, 1988
8. Preiksaitis JK, Rosno S, Grumet C, Merigan TC: Infections due to herpes viruses in cardiac transplant recipients: Role of the donor heart and immunosuppressive therapy. J Infect Dis 147:974, 1983
9. Winston DJ, Ho WG, Lin CH, Budinger MD, Champlin RE, Gale RP: Delay in platelet recovery after bone marrow transplantation: Impact of cytomegalovirus infection. Am J Med 106:128, 1984
10. Verdonck LF, van Heugten H, de Gast GC: Delay in platelet recovery after bone marrow transplantations: Impact of cytomegalovirus infection. Blood 66:921, 1985
11. Verdonck LF, van Heugten H, de Gast GC, Nieuwenhuis HK, Dekker AW: Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood 78:844, 1991
12. Bolger GB, Sullivan KM, Storb R, Witherspoon RP, Weiden PL, Stewart P, Sanders J, Meyers JD, Martin PJ, Doney KC, Deeg HJ, Clift RA, Buckner CD, Appelbaum FR, Thomas ED: Second marrow infusion for poor graft function after allogenic marrow transplantation. Bone Marrow Transplant 1:21, 1986
13. Mutter W, Reddehase MF, Busche FW, Buhring HJ, Koszinowski WH: Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immuno-compromised host. J Exp Med 167:1645, 1988
14. Suwansirikul S, Rao N, Dowling JN, Ho M: Primary and secondary cytomegalovirus infection. Clinical manifestations after renal transplantation. Arch Intern Med 137:1026, 1977
15. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG: Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 98:281, 1981
16. Hanshaw JB: Cytomegalovirus, in Remington JS, Klein JO (eds): Infectious Diseases of the Fetus and Newborn Infant (ed 2). Philadelphia, PA, Saunders. 1983, p 104
17. Rakusan TA, Patten ED, Richardson CJ, Pollard RB: Neutro-penia associated with congenital cytomegalovirus infection. Clin Res 32:894A, 1984
18. Skar AG, Hoddevik G: Prevalence of cytomegalovirus in Norwegian kidney transplant recipients and their living donors. Acta Pathol Microbiol Scand Sect B 92:1, 1984
19. Apperley JF, Dowding C, Hibbin J, Buiter J, Matutes E, Sissons PJ, Gordon M, Goldman JM: The effect of cytomegalovirus on hematopoiesis: In vitro evidence for selective infection of marrow stromal cells. Exp Hematol 17:38, 1989
20. Maciewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC: Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170, 1992
21. Jordan MC: Latent infection and the elusive cytomegalovirus. Rev Infect Dis 5:205, 1983
22. Lang DJ, Scolnick EM, Willerson JT: Association of cytomegalovirus infection with the postperfusion syndrom. N Engl J Med 278:1147, 1968
23. Lang DJ, Ebert PA, Rodgers BM, Boggess HP, Rixse RS: Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood. Transfusion 17:391, 1977
24. Tolkoff-Rubin NE, Rubin RH, Keller EE, Baker GP, Stewart JA. Hirsch MS: Cytomegalovirus infection in dialysis patients and personnel. Ann Intern Med 89:625, 1978
25. Taylor-Wiedeman JA, Hayhurst GP, Sissons JGP, Sinclair JH: Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol 74:265, 1993
26. Taylor-Wiedemann JA, Sissons JGP, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:1059, 1991
27. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 91:11879, 1994
28. Rakusan TA, Juneja HS, Fleischmann WR: Inhibition of hemopoietic colony formation by human cytomegalovirus in vitro. J Infect Dis 159:127, 1989
29. Sing GK, Ruscetti FW: Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 75:1965, 1990
30. MacKintosh FR, Adlish J, Hall SW, St Jeor S, Smith E, Tavassoli M, Zanjani ED: Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol 21:243, 1993
31. Holberg-Petersen M, Rollag H, Beck S, Øverli I, Tjønnfjord G, Abrahamsen TG, Degré M, Hestdal K: Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro. Blood (in press)
32. Verfaillie CM, Blakholmer K, McGlave PB: Purified primitive human hematopoietic progenitors with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 172:509, 1990
33. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003, 1992
34. Srour EF, Zanjani ED, Brandt JE, Leemhuis T, Briddell RA, Heerema NA, Hoffman R: Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells. Blood 79:1404, 1992
35. Briddell RA, Broudy VC, Bruno E, Brandt JE, Srour EF, Hoffman R: Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 79:3159, 1992
36. - progenitor cells. Blood 77:1218, 1991
37. Andrews RG, Singer JW, Bernstein ID: Precursors of colonyforming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721, 1989
38. Baum CM, Weissman I, Tsukamoto AS, Buckle AM, Peault B: Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804, 1992
39. Craig W, Kay R, Cutler TL, Lansdorp PM: Expression of Thy-l on human progenitor cells in mouse bone marrow. Blood 54:1446, 1979
40. + cells: Methodology and monoclonal antibodies, in Wunder E. Sovalat H, Hénon PR, Serke S (eds): Hematopoietic Stem Cells. The Mullhouse Manual. Dayton, OH, AlphaMed, 1994, p 141
41. + bone marrow cells. J Exp Med 177:1531, 1993
42. Barzilai R, Lazarus LH, Goldblum N: Viscosity-density gradient for purification of foot-and-mouth disease virus. Arch Ges Virusforsch 36:141, 1972
43. Talbot P, Almeida JD: Human cytomegalovirus: Purification of enveloped virions and dense bodies. J Gen Virol 36:345, 1977
44. Demmler GJ, Buffone GJ, Schimbor CM, May RA: Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 158:1177, 1988
45. Shibata D, Martin WJ, Appleman MD, Causey DM, Leedom JM, Arnheim N: Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis 158:1185, 1988
46. Holberg-Petersen M, Bukholm G, Rollag H, Degré M: Infection with human cytomegalovirus enhances bacterial adhesiveness and invasiveness in permissive and semipermissive cells. APMIS 102:703, 1994
47. Simmons P, Kaushansky K, Torok-Storb B: Mechanisms of cytomegalovirus-mediated myelosuppression: Perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 87:1386, 1990
48. Bradley TR, Hodgson GS: Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 54:1446, 1979
49. McNiece IK, Bertoncello I, Kriegler AB, Quesenberry PJ: Colony-forming cells with high proliferative potential. Int J Cell Cloning 8:146, 1990
50. Sinclair J, Sissons JGP: Human cytomegalovirus, pathegenesis and models of latency. Semin Virol 5:249, 1994
51. Minton EJ, Tysoe C, Sinclair JH, Sissons JGP: Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 68:4017, 1994
52. + bone marrow cells. Blood 84:1473, 1994
53. Liu B, Stinski MF: Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol 66:4434, 1992
54. Novak J, Sova P, Krchnak V, Hamsikova E, Zavadova H, Roubal J: Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides. J Gen Virol 72:1409, 1991